Cargando…
Reduced Expression of Syndecan‐1 Affects Metastatic Potential and Clinical Outcome in Patients with Colorectal Cancer
Syndecan‐1 is a transmembrane heparansulfate proteoglycan which regulates cell‐to‐cell or cell‐to‐extracellular matrix interactions and may influence malignant cell behavior. We investigated the alterations of syndecan‐1 expressions in colorectal cancers and analyzed the relationship between histolo...
Autores principales: | Fujiya, Mikihiro, Watari, Jiro, Ashida, Toshifumi, Honda, Mitsunori, Tanabe, Hiroki, Fujiki, Takanori, Saitoh, Yusuke, Kohgo, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926619/ https://www.ncbi.nlm.nih.gov/pubmed/11676858 http://dx.doi.org/10.1111/j.1349-7006.2001.tb01062.x |
Ejemplares similares
-
Back-to-Back Comparison of Auto-Fluorescence Imaging (AFI) Versus High Resolution White Light Colonoscopy for Adenoma Detection
por: Moriichi, Kentaro, et al.
Publicado: (2012) -
Traffic Control of Bacteria-Derived Molecules: A New System of Host-Bacterial Crosstalk
por: Konishi, Hiroaki, et al.
Publicado: (2013) -
A Bamboo Joint-Like Appearance is a Characteristic Finding in the Upper Gastrointestinal Tract of Crohn's Disease Patients: A Case-Control Study
por: Fujiya, Mikihiro, et al.
Publicado: (2015) -
Immune checkpoint inhibitor‐related gastritis in a patient with metastatic melanoma
por: Sugiyama, Yuya, et al.
Publicado: (2021) -
Infliximab Extends the Duration until the First Surgery in Patients with Crohn's Disease
por: Sakatani, Aki, et al.
Publicado: (2013)